EGFR and neoplasm: Resistance to EGFR-TKIs depends on modifications of the initial tumor tissue with different possibilities: increasing of the presence of sub-clonal populations with intrinsic resistance to TKIs under therapeutic pressure, tumor mutability with de novo molecular alterations, or tumor capacities to develop adaptive resistance by histological transformation.